Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional

Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

ClinicalTrials.gov ID: NCT02341560

Public ClinicalTrials.gov record NCT02341560. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 10:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will determine the effect of QPI-1007 on visual function in subjects with recent-onset NAION and assess the safety and tolerability of intravitreal injections of QPI-1007 in this population. This study will also evaluate the structural changes in the retina following administration of QPI-1007.

Study identification

NCT ID
NCT02341560
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Quark Pharmaceuticals
Industry
Enrollment
732 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 24, 2016 (Actual)
Primary completion
Jul 1, 2019 (Actual)
Completion
Jul 1, 2019 (Actual)
Last update posted
Jul 20, 2020

2016 – 2019

United States locations

U.S. sites
44
U.S. states
24
U.S. cities
38
Facility City State ZIP Site status
University of Arkansas Medical Center, Jones Eye Institute Little Rock Arkansas 72205 —
Loma Linda University Eye Institute Loma Linda California 92354 —
University of Southern California Los Angeles California 90033 —
NeuroEyeOrbit Institute Los Angeles California 90048 —
Stanford University Palo Alto California 94303 —
Unversity of California, Los Angeles (UCLA) Pasadena California 91105 —
University of Colorado Denver, Department of Neurology Aurora Colorado 80045 —
Retina Consultants of Southern Colorado, PC Colorado Springs Colorado 80909 —
The Eye Care Group Waterbury Connecticut 06708 —
Cape Coral Eye Center Cape Coral Florida 33904 —
University of Miami Miller School of Medicine/Bascom Palmer Eye Institute Miami Florida 33136 —
Sarasota Retina Institute Sarasota Florida 34239 —
Northwestern University Chicago Illinois 60611 —
University of Illinois at Chicago, Department of Ophthalmology (MC 648) Chicago Illinois 60612 —
NorthShore University Healthsystem Glenview Illinois 60026 —
University of Kentucky, Department of Neurology Lexington Kentucky 40536 —
Greater Baltimore Medical Center Baltimore Maryland 21204 —
Bethesda Neurology, LLC Bethesda Maryland 20852 —
Massachusetts Eye and Ear Infirmary Boston Massachusetts 02114 —
Boston Medical Center Boston Massachusetts 21118 —
University of Michigan Ann Arbor Michigan 48105 —
University of Minnesota Minneapolis Minnesota 55455 —
Mayo Clinic Rochester Minnesota 55905 —
Washington University in St. Louis St Louis Missouri 63110 —
University of Nebraska Medical Center and Truhlsen Eye Institute Omaha Nebraska 68198 —
Rutgers, New Jersey Medical School Newark New Jersey 07103 —
New York Eye and Ear Infirmary of Mount Sinai New York New York 10003 —
Cornell University School of Medicine New York New York 10583 —
University of Rochester, Flaum Eye Institute Rochester New York 14642 —
State University of New York at Stony Brook Stony Brook New York 11794 —
SUNY Upstate Medical University Syracuse New York 13210 —
Duke University Eye Center Durham North Carolina 27705 —
Raleigh Neurology Associates Raleigh North Carolina 27607 —
Cleveland Clinic, Cole Eye Institute Cleveland Ohio 44195 —
Dean McGee Eye Institute Oklahoma City Oklahoma 73013 —
University of Pennsylvania, Scheie Eye Institute Philadelphia Pennsylvania 19104 —
Retina Consultants of Charleston Charleston South Carolina 29414 —
University of Houston, Neuro-Ophth of Texas Houston Texas 77025 —
Houston Methodist Hospital, Blanton Eye Institute Houston Texas 77030 —
Foresight Studies San Antonio Texas 78240 —
University of Utah John A. Moran Eye Center Salt Lake City Utah 84132 —
University of Virginia Health Sciences Center Charlottesville Virginia 22908 —
Swedish Medical Center, CO/NOCNW Seattle Washington 98104 —
University of Washington Department of Ophthalmology Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02341560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2020 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02341560 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →